Inspire Investing’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-34,442
Closed -$2.55M 818
2023
Q4
$2.55M Buy
34,442
+2,222
+7% +$146K 0.28% 79
2023
Q3
$2.2M Buy
32,220
+5,742
+22% +$487K 0.28% 83
2023
Q2
$2.49M Sell
26,478
-12,354
-32% -$964K 0.3% 79
2023
Q1
$2.63M Buy
38,832
+34,059
+714% +$2.19M 0.34% 68
2022
Q4
$236K Sell
4,773
-1,542
-24% -$63K 0.03% 444
2022
Q3
$205K Sell
6,315
-19,439
-75% -$801K 0.03% 697
2022
Q2
$1.01M Buy
25,754
+2,552
+11% +$136K 0.13% 132
2022
Q1
$1.62M Sell
23,202
-2,581
-10% -$189K 0.19% 121
2021
Q4
$2.01M Buy
25,783
+1,822
+8% +$161K 0.23% 113
2021
Q3
$2.29M Buy
+23,961
New +$2.53M 0.29% 89
2018
Q1
Sell
-1,104
Closed -$58K 357
2017
Q4
$58K Buy
+1,104
New +$58.9K 0.05% 383

Other funds holding EXAS

Inspire Investing's EXAS Position: Q1 2024 in Review

Inspire Investing sold out of Exact Sciences (EXAS) in Q1 2024, closing a stake of 34,442 shares — an estimated $2.55M sold.

Inspire Investing first reported a position in EXAS in Q4 2017 and held it in 11 quarters. The position peaked at $2.63M in Q1 2023. 626 funds tracked by Wall St. Rank hold EXAS as of Q1 2024.

  • Inspire Investing reported no remaining Exact Sciences position as of Q1 2024 after selling out during the quarter.
  • Inspire Investing sold 34,442 Exact Sciences shares in Q1 2024, an estimated $2.55M.
  • Inspire Investing first reported a position in Exact Sciences in Q4 2017 and held it in 11 quarters.
  • Inspire Investing's Exact Sciences position peaked at $2.63M in Q1 2023.
  • 626 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2024.

Based on Inspire Investing's 13F filing for Q1 2024, filed 7 May 2024.